National control laboratory independent lot testing of COVID-19 vaccines: the UK experience
Abstract The past 18 months have seen an unprecedented approach to vaccine development in the global effort against the COVID-19 pandemic. The process from discovery research, through clinical trials and regulatory approval often takes more than 10 years. However, the critical need to expedite vacci...
Main Authors: | Nicola J. Rose, Paul Stickings, Silke Schepelmann, Marc J. A. Bailey, Chris Burns |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-08-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-021-00368-7 |
Similar Items
-
Independent Selection of Judges via Competence Evaluation and Lot
by: Anne Sanders, et al. -
SiMa Cells for a Serotype Specific and Sensitive Cell-Based Neutralization Test for Botulinum Toxin A and E
by: Nicola Bak, et al.
Published: (2017-07-01) -
Lot verification practices in Ontario clinical chemistry laboratories - Results of a patterns-of-practice survey
by: Angela C. Rutledge, et al.
Published: (2022-11-01) -
"Most People See That The UK Is A Lot Better Off Within The EU"
by: Jo Shaw -
Rational arguments for regulatory acceptance of consistency testing: benefits of non-animal testing over in vivo release testing of vaccines
by: Marcel H.N. Hoefnagel, et al.
Published: (2023-12-01)